🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

15 notícias encontradas para "therapeutics"
Experts convened by WHO advise on candidate treatments and vaccines for Ebola disease caus
In response to the current outbreak of Ebola disease caused by Bundibugyo virus occurring in the Democratic Republic of the Congo, with cases also reported in Uganda, WHO convened several of its expert and advisory groups. These groups assessed potential vaccines and therapeutics
Keeping HIV at bay: New approach explores broadly neutralizing antibodies to treat infants
In the ongoing effort to find new therapeutics for infants born infected with the human immunodeficiency virus, an international team of investigators has discovered that babies can tolerate treatment with anti-HIV antibodies.
FDA approves first treatment for thyroid eye disease
The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED). Approval was granted to Viridian Therapeutics.
Clinician support key to patient adoption of VR therapies, study suggests
Clinician support key to patient adoption of VR therapies, study suggests
A new study published in JMIR XR and Spatial Computing demonstrates that the way virtual reality therapeutics (VRx) are introduced to patients is a critical factor in how successfully they adopt the technology. The randomized feasibility pilot study builds on growing evidence tha
Ipsen to buy Kartos Therapeutics for $450M to boost oncology pipeline
A pauta traz uma atualização relevante e serve como base para a cobertura editorial. O recorte ajuda a contextualizar a pauta dentro de Finanças.
Travere Therapeutics stock hits 52-week high at 56.9 USD
Travere Therapeutics stock hits 52-week high at 56.9 USD
A pauta traz uma atualização relevante e serve como base para a cobertura editorial. O recorte ajuda a contextualizar a pauta dentro de Economia.
Form 4 Kymera Therapeutics Inc For: 25 June
Form 4 Kymera Therapeutics Inc For: 25 June
A pauta traz uma atualização relevante e serve como base para a cobertura editorial. O recorte ajuda a contextualizar a pauta dentro de Economia.
Form 4 Kymera Therapeutics Inc For: 25 June
Form 4 Kymera Therapeutics Inc For: 25 June
A pauta traz uma atualização relevante e serve como base para a cobertura editorial. O recorte ajuda a contextualizar a pauta dentro de Economia.
Form 4 MapLight Therapeutics Inc For: 25 June
Form 4 MapLight Therapeutics Inc For: 25 June
A pauta traz uma atualização relevante e serve como base para a cobertura editorial. O recorte ajuda a contextualizar a pauta dentro de Economia.
Form 4 MapLight Therapeutics Inc For: 25 June
Form 4 MapLight Therapeutics Inc For: 25 June
A pauta traz uma atualização relevante e serve como base para a cobertura editorial. O recorte ajuda a contextualizar a pauta dentro de Economia.
Form 144 Kymera Therapeutics For: 13 July
Form 144 Kymera Therapeutics For: 13 July
A pauta traz uma atualização relevante e serve como base para a cobertura editorial. O recorte ajuda a contextualizar a pauta dentro de Economia.
Foto: Andre Moura / Pexels
Structural blueprint for RNA therapeutics reveals why some siRNA molecules work better tha
RNA interference is a natural mechanism for living cells to control whether specific genes are being used. Crowned with the 2006 Nobel Prize in Physiology or Medicine, the discovery of RNA interference has since been harnessed by scientists to create a powerful and growing class